Nkarta, Inc. (NKTX)
2.69
-0.07
(-2.54%)
USD |
NASDAQ |
Aug 31, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
Nkarta Cash from Operations (Annual) : -88.70M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -88.70M |
| December 31, 2024 | -99.70M |
| December 31, 2023 | -86.16M |
| December 31, 2022 | -57.00M |
| Date | Value |
|---|---|
| December 31, 2021 | -67.93M |
| December 31, 2020 | -43.51M |
| December 31, 2019 | -18.37M |
| December 31, 2018 | -5.184M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Theriva Biologics, Inc. | -16.67M |
| Unicycive Therapeutics, Inc. | -31.32M |
| OnKure Therapeutics, Inc. | -51.83M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |